Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases
May 22, 2026
Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange
March 13, 2023
Related Post
-
-
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT(TM) at ASCO 2026
May 22, 2026
-
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
May 22, 2026
-
BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 22, 2026